Trial Profile

A Phase 1/2a , first-in-human trial of AMA005 in hemophilia B patients

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 21 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AMA 005 (Primary)
Indications Haemophilia B
Focus Adverse reactions; First in man

Most Recent Events

21 Dec 2021 New trial record
01 Dec 2021 According to an Amarna Therapeutics media release, the company is planning to initiate this study in approximately two years. The company has recently engaged HALIX, a leading biopharmaceutical contract development and manufacturing organization (CDMO), to produce the clinical trial material.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com